➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Colorcon
McKinsey
Mallinckrodt

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,058,564


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,058,564 protect, and when does it expire?

Patent 10,058,564 protects ORACEA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 10,058,564
Title:Methods of treating acne
Abstract: A method of treating acne in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat acne but has substantially no antibiotic activity, without administering a bisphosphonate compound.
Inventor(s): Ashley; Robert A. (Newtown, PA)
Assignee: Galderma Laboratories Inc. (Fort Worth, TX)
Application Number:15/004,619
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,058,564
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 10,058,564

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Galderma Labs Lp ORACEA doxycycline CAPSULE;ORAL 050805-001 May 26, 2006 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial TREATMENT OF ONLY INFLAMMATORY LESIONS (PAPULES AND PUSTULES) OF ROSACEA ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,058,564

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 330615 ⤷  Free Forever Trial
Australia 2002303250 ⤷  Free Forever Trial
Canada 2440472 ⤷  Free Forever Trial
Canada 2719162 ⤷  Free Forever Trial
Germany 60212613 ⤷  Free Forever Trial
Denmark 1383508 ⤷  Free Forever Trial
European Patent Office 1383508 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Merck
Express Scripts
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.